Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Thomas Brott"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michelle Lin, Nihas Mateti, Young Erben, Kevin Barrett, Nilufer Taner, Thomas Brott, James Meschia
Publikováno v:
Thursday, April 27.
Autor:
Hossam Youssef, Nihas Mateti, Demirer Mutlu, Erik Middlebrooks, Thomas Brott, Nilufer Taner, James Meschia, Michelle Lin
Publikováno v:
Wednesday, April 26.
Autor:
Michelle Lin, Mutlu Demirer, Erik Middlebrooks, Bhrugun Anisetti, Hossam Youssef, Ahamed Elkhair, Kevin M Barrett, Thomas Brott, James F Meschia
Publikováno v:
Stroke. 53
Introduction: Patients with carotid stenosis may have silent cerebrovascular disease due to chronic hypoperfusion and atheroembolism. If so, progression of silent disease may be preventable through revascularization. We aim to evaluate the associatio
Autor:
Kennedy R. Lees, Jonathan Emberson, Lisa Blackwell, Erich Bluhmki, Stephen M. Davis, Geoffrey A. Donnan, James C. Grotta, Markku Kaste, Rüdiger von Kummer, Maarten G. Lansberg, Richard I. Lindley, Patrick Lyden, Gordon D. Murray, Peter A.G. Sandercock, Danilo Toni, Kazunori Toyoda, Joanna M. Wardlaw, William N. Whiteley, Colin Baigent, Werner Hacke, George Howard, John Marler, Heather Halls, Lisa Holland, Clare Mathews, Samantha Smith, Kate Wilson, Masatoshi Koga, Gregory Albers, Thomas Brott, Geoffrey Cohen, Jean Marc Olivot, Mark Parsons, Barbara Tilley, Nils Wahlgren, Gregory J del Zoppo
Publikováno v:
Stroke. 47:2373-2379
Background— Thrombolytic therapy with intravenous alteplase within 4.5 hours of ischemic stroke onset increases the overall likelihood of an excellent outcome (no, or nondisabling, symptoms). Any improvement in functional outcome distribution has v
Autor:
Judith H Lichtman, Erica Leifheit-Limson, Yun Wang, James F Meschia, George Howard, Virginia Howard, Thomas Brott
Publikováno v:
Stroke. 47
Background: Over 9 million dual-eligible beneficiaries rely on both Medicare and Medicaid to obtain critical medical services. Medicaid serves as a safety net for low-income Medicare beneficiaries with limited assets; however, it is unknown whether d
Autor:
William G. Barsan, Thomas Brott
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 1(4)
Autor:
Thomas Kwiatkowski, Richard Libman, Barbara C. Tilley, Christopher Lewandowski, James C. Grotta, Patrick Lyden, Steven R. Levine, Thomas Brott, null the National Institute of Neurolo
Publikováno v:
Annals of Emergency Medicine. 45:377-384
Study objective The National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator (rtPA) Stroke Study demonstrated a clinically meaningful and statistically significant benefit of tissue plasminogen activato
Autor:
Josep, Rodés-Cabau, Philip, Kahlert, Franz-Josef, Neumann, Gerhard, Schymik, John G, Webb, Pierre, Amarenco, Thomas, Brott, Zsolt, Garami, Gino, Gerosa, Thierry, Lefèvre, Bjoern, Plicht, Stuart J, Pocock, Marc, Schlamann, Martyn, Thomas, Beverly, Diamond, Ihsen, Merioua, Friedhelm, Beyersdorf, Alec, Vahanian
Publikováno v:
JACC. Cardiovascular interventions. 7(10)
This study sought to determine the feasibility, safety, and exploratory efficacy of the Embrella Embolic Deflector (EED) system (Edwards Lifesciences, Irvine, California) in patients undergoing transcatheter aortic valve replacement (TAVR).Few data e
Autor:
John R. Marler, Christy M. Jackson, Patrick D. Lyden, Justin A. Zivin, Rashmi Kothari, Mei Lu, Thomas Brott
Publikováno v:
Stroke. 30:2347-2354
Background and Purpose —No stroke scale has been validated as an outcome measure using data from a clinical trial demonstrating a positive therapeutic effect. Therefore, we proposed to use data from the National Institute of Neurological Disorders